vs
Side-by-side financial comparison of Pulmonx Corp (LUNG) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
SYPRIS SOLUTIONS INC is the larger business by last-quarter revenue ($30.3M vs $20.6M, roughly 1.5× Pulmonx Corp). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -66.3%, a 53.4% gap on every dollar of revenue. On growth, Pulmonx Corp posted the faster year-over-year revenue change (-8.7% vs -9.5%). Over the past eight quarters, Pulmonx Corp's revenue compounded faster (-0.5% CAGR vs -7.7%).
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
LUNG vs SYPR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $30.3M |
| Net Profit | $-13.7M | $-3.9M |
| Gross Margin | 77.9% | 4.6% |
| Operating Margin | -40.9% | -10.9% |
| Net Margin | -66.3% | -12.9% |
| Revenue YoY | -8.7% | -9.5% |
| Net Profit YoY | 5.5% | -2992.6% |
| EPS (diluted) | $-0.33 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $30.3M | ||
| Q3 25 | $21.5M | $28.7M | ||
| Q2 25 | $23.9M | $31.4M | ||
| Q1 25 | $22.5M | $29.5M | ||
| Q4 24 | $23.8M | $33.4M | ||
| Q3 24 | $20.4M | $35.7M | ||
| Q2 24 | $20.8M | $35.5M |
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $-3.9M | ||
| Q3 25 | $-14.0M | $517.0K | ||
| Q2 25 | $-15.2M | $-2.1M | ||
| Q1 25 | $-14.4M | $-899.0K | ||
| Q4 24 | $-13.2M | $135.0K | ||
| Q3 24 | $-14.1M | $390.0K | ||
| Q2 24 | $-15.3M | $16.0K |
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | 4.6% | ||
| Q3 25 | 74.7% | 7.2% | ||
| Q2 25 | 72.1% | 8.2% | ||
| Q1 25 | 72.5% | 11.4% | ||
| Q4 24 | 74.0% | 16.1% | ||
| Q3 24 | 73.7% | 16.8% | ||
| Q2 24 | 73.7% | 15.9% |
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | -10.9% | ||
| Q3 25 | -66.9% | -6.1% | ||
| Q2 25 | -62.0% | -4.6% | ||
| Q1 25 | -64.6% | -0.4% | ||
| Q4 24 | -56.5% | 3.9% | ||
| Q3 24 | -69.3% | 4.8% | ||
| Q2 24 | -75.2% | 3.6% |
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | -12.9% | ||
| Q3 25 | -64.9% | 1.8% | ||
| Q2 25 | -63.6% | -6.5% | ||
| Q1 25 | -64.1% | -3.0% | ||
| Q4 24 | -55.4% | 0.4% | ||
| Q3 24 | -69.4% | 1.1% | ||
| Q2 24 | -73.7% | 0.0% |
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | $-0.17 | ||
| Q3 25 | $-0.34 | $0.02 | ||
| Q2 25 | $-0.38 | $-0.09 | ||
| Q1 25 | $-0.36 | $-0.04 | ||
| Q4 24 | $-0.33 | $0.00 | ||
| Q3 24 | $-0.36 | $0.02 | ||
| Q2 24 | $-0.39 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $61.6M | — |
| Total DebtLower is stronger | $37.3M | — |
| Stockholders' EquityBook value | $45.8M | $17.8M |
| Total Assets | $120.0M | $107.8M |
| Debt / EquityLower = less leverage | 0.82× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | — | ||
| Q3 25 | $76.5M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $74.6M | — | ||
| Q4 24 | $70.9M | — | ||
| Q3 24 | $63.3M | — | ||
| Q2 24 | $63.5M | — |
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | — | ||
| Q3 25 | $37.1M | — | ||
| Q2 25 | $37.1M | — | ||
| Q1 25 | $37.2M | — | ||
| Q4 24 | $37.2M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | $37.2M | — |
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $17.8M | ||
| Q3 25 | $60.0M | $20.0M | ||
| Q2 25 | $69.1M | $18.7M | ||
| Q1 25 | $77.7M | $19.0M | ||
| Q4 24 | $85.8M | $19.6M | ||
| Q3 24 | $93.9M | $18.2M | ||
| Q2 24 | $101.2M | $19.0M |
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $107.8M | ||
| Q3 25 | $138.3M | $112.5M | ||
| Q2 25 | $147.2M | $105.8M | ||
| Q1 25 | $150.7M | $110.2M | ||
| Q4 24 | $162.8M | $119.4M | ||
| Q3 24 | $167.4M | $121.6M | ||
| Q2 24 | $172.6M | $124.2M |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.37× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-1.5M |
| FCF MarginFCF / Revenue | — | -5.0% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-1.1M | ||
| Q3 25 | $-8.2M | $-178.0K | ||
| Q2 25 | $-3.9M | $1.1M | ||
| Q1 25 | $-13.2M | $-5.5M | ||
| Q4 24 | $-6.7M | $2.3M | ||
| Q3 24 | $-7.2M | $-4.8M | ||
| Q2 24 | $-5.8M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-1.5M | ||
| Q3 25 | $-8.3M | $-390.0K | ||
| Q2 25 | $-4.0M | $941.0K | ||
| Q1 25 | $-13.5M | $-5.5M | ||
| Q4 24 | $-6.8M | $1.9M | ||
| Q3 24 | $-7.7M | $-4.9M | ||
| Q2 24 | $-6.2M | $6.0M |
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | -5.0% | ||
| Q3 25 | -38.4% | -1.4% | ||
| Q2 25 | -16.6% | 3.0% | ||
| Q1 25 | -60.0% | -18.8% | ||
| Q4 24 | -28.8% | 5.7% | ||
| Q3 24 | -37.6% | -13.8% | ||
| Q2 24 | -30.0% | 16.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 1.3% | ||
| Q3 25 | 0.4% | 0.7% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 0.5% | 1.2% | ||
| Q3 24 | 2.0% | 0.4% | ||
| Q2 24 | 2.3% | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUNG
Segment breakdown not available.
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
